3rd Quarter - Report
W STRATEGIES, LLC for ABBOTT LABORATORIES
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
H.R. 2207: Protect Medical Innovation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Health Issues HCR
Development of legislation regulated to regulation of LDTs, including a discussion draft of VALID Act. H.R.2113: Prescription Drug STAR Act. H.R.2064: Sunshine for Samples Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Defense DEF
FY 2020 NDAA - education about CGM coverage in TRICARE.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.